Home » Newsletters » BioWorld

BioWorld

Jan. 22, 1993

View Archived Issues

LIFECELL TO ACCELERATE ALLODERM TRIALS

CELLPRO BEGINS CANCER TRIALS

IL-1 RESEARCHER AT ODDS WITH ANALYST

FDA APPROVES SERAGEN'S IL-2 TRIALS

BUSY BEGINNING FOR PUBLIC OFFERINGS

AUTOIMMUNE GOES PUBLIC WITH $41M IPO